Substitution of Propofol by Sevoflurane During Pediatric Cardiopulmonary Bypass (PRISKIKO)
|ClinicalTrials.gov Identifier: NCT01295190|
Recruitment Status : Completed
First Posted : February 14, 2011
Last Update Posted : May 22, 2014
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||200 participants|
|Official Title:||Substitution of Propofol by Sevoflurane During Pediatric Cardiopulmonary Bypass: Effect on Metabolic Acidosis and Clinical Outcome|
|Study Start Date :||June 2009|
|Actual Primary Completion Date :||August 2010|
|Actual Study Completion Date :||August 2010|
Patients receiving Propofol during cardiopulmonary bypass.
Patients receiving sevoflurane during cardiopulmonary bypass
- Metabolic acidosis during cardiopulmonary bypass [ Time Frame: 2 hours ]Changes of pH, base excess and lactate relative to baseline are analysed.
- Outcome parameter [ Time Frame: 1 month ]Duration of intensive care treatment and time to dismission from hospital are compared between groups.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01295190
|University Hospital Schleswig-Holstein|
|Kiel, Schleswig-Holstein, Germany, 24105|
|Principal Investigator:||Axel Fudickar, Dr.||University of Schleswig-Holstein|